Patients News | pharmaphorum

News

Apellis slides on side effect reports with new eye drug

Apellis' share price came under pressure today after it revealed new details about a rare but serious side effect with its recently-approved Syfovre therapy for eye diseas

News

Purdue bankruptcy case elevated to SCOTUS

The US Government has asked the Supreme Court to block Purdue Pharma from completing a bankruptcy settlement that would shield its Sackler family owners from lawsuits.

News

NICE won't budge on rejection of rare disease drug

The UK's cost-effectiveness agency NICE has delivered its final verdict on Clinuvel's Scenesse, a treatment for a rare skin disorder that causes extreme sensitivity to lig

News

Eversana and Amazon plan generative AI push in pharma

There's a lot of talk about the role that generative artificial intelligence (AI) will have to play in the pharma industry, and a new alliance between Eversana and Amazon

News

Switch study says patients prefer ViiV’s injectable HIV drug

When ViiV Healthcare and Johnson & Johnson launched their once-monthly injectable HIV treatment Cabenuva in 2021, they predicted that patients would prefer that option

News

Bayer drug raises hope for 1.5bn people with worm diseases

More than 1.5 billion people around the world are infected with soil-transmitted helminths (STHs), parasitic worms that damage their health and are a leading cause of maln

Apellis slides on side effect reports with new eye drug

Purdue bankruptcy case elevated to SCOTUS

NICE won't budge on rejection of rare disease drug

Eversana and Amazon plan generative AI push in pharma

Switch study says patients prefer ViiV’s injectable HIV drug

Bayer drug raises hope for 1.5bn people with worm diseases

BridgeBio gains on phase 3 dwarfism data

How to meet your physicians where they are online

News

Editor's Picks